{!{types field=’prefix’ separator=’, ‘}!}{!{/types}!} {!{types field=’first-name’}!}{!{/types}!} {!{types field=’last-name’}!}{!{/types}!}

{!{types field=’degrees-or-credentials’ separator=’, ‘}!}{!{/types}!}

Genesys Capital

{!{types field=’position’ separator=’, ‘}!}{!{/types}!}

Research Interests:

Brief Bio:

Dr. Farr joined Genesys Capital in 2020 as an Associate, bringing to the team eight years of experience at the bench in laboratory research and discovery. Before Genesys, Dr. Farr worked as a Business Development Officer in the Industry Partnerships & Commercialization office at the Hospital for Sick Children, where she identified commercial opportunities, managed industry partnerships, and handled the Research Institute’s intellectual property. She also led company creation efforts around a lead spin-off opportunity, including engagement of investors, pharma partners, and KOLs. Dr. Farr holds a PhD from the Faculty of Medicine at the University of Toronto where she studied the effects of an anti-diabetic hormone on lipid and lipoprotein metabolism. She also has a Bachelor of Health Science (Honours) with a minor in Biochemistry from McMaster University.

{!{types field=’prefix’ separator=’, ‘}!}{!{/types}!} {!{types field=’first-name’}!}{!{/types}!} {!{types field=’last-name’}!}{!{/types}!}

{!{types field=’degrees-or-credentials’ separator=’, ‘}!}{!{/types}!}

Genesys Capital

{!{types field=’position’ separator=’, ‘}!}{!{/types}!}

Research Interests:

Brief Bio:

Dr. Farr joined Genesys Capital in 2020 as an Associate, bringing to the team eight years of experience at the bench in laboratory research and discovery. Before Genesys, Dr. Farr worked as a Business Development Officer in the Industry Partnerships & Commercialization office at the Hospital for Sick Children, where she identified commercial opportunities, managed industry partnerships, and handled the Research Institute’s intellectual property. She also led company creation efforts around a lead spin-off opportunity, including engagement of investors, pharma partners, and KOLs. Dr. Farr holds a PhD from the Faculty of Medicine at the University of Toronto where she studied the effects of an anti-diabetic hormone on lipid and lipoprotein metabolism. She also has a Bachelor of Health Science (Honours) with a minor in Biochemistry from McMaster University.